ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Technology / XLAB / insiders
ZENA (46) DUOT (32) AEYE (41) PDYN (15) ⌘ Pro Terminal →

Exascale Labs Holdings Inc. (Class A) (XLAB) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$2.04 -28.17% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.93

Exascale Labs Holdings Inc. (Class A) (XLAB) carries a Roarable Rating of E (Strong Sell) with 28/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $182.7M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on XLAB Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is XLAB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Exascale Labs Holdings Inc. (Class A) (NASDAQ: XLAB) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 28/100 at a spot price of $2.04 (-28.17% 1D, market cap $182.7M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 5/20, and Executive Insider Alignment 3/20. Across 715 tracked Technology issuers, XLAB ranks #624 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does XLAB compare to ZENA and DUOT in the Technology sector?
▼

Within the Technology sector (Computer Software: Prepackaged Software), XLAB carries a Roarable E (28/100 RQD), trailing P/E of N/A, gross margin of 15.8%, and ROIC of -23.7%. By comparison, ZENA (ZenaTech Inc.) holds a D grade (46/100 RQD, P/E N/A, ROIC —, cap $175.5M) and DUOT (Duos Technologies Group Inc.) posts a E grade (32/100 RQD, P/E N/A, ROIC -15.9%, cap $195.1M). Among the 5-stock peer group, PDYN leads on earnings multiple (18.1x) while AEYE leads on capital efficiency (-12.1% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for XLAB?
▼

Per XLAB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0002109869), Exascale Labs Holdings Inc. (Class A) generated $7.0M in revenue, -$7.7M in net income, and -$1.0M in free cash flow against $0 in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $1.93 (-5.26%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 7/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (28/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-10.0% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • E
025507510028
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk E
Cash (7)Whales (5)SEC (8)Macro (5)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-13.7% Base Target
$12 Bull$2 Base$1 Bear
📬 FREE XLAB RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for XLAB)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (28/100 Composite)
🔍 WHY XLAB SCORES 28/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (29% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 1/9

▲ #2 Bullish Driver: Cash Engine Quality+7/20 pts (25% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 15.8% Gross Margin

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
20
Grade E$0.93+221.5% Next Q
Q2 (-2Q)
23
Grade E$2.99+3% Next Q
Q3 (-1Q)
25
Grade E$3.08-33.8% Next Q
Current
28
Grade E$2.04-10% Hist 90D α
Trajectory: E (20) → E (28)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a XLAB Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While XLAB currently carries a cautious 28/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Technology with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.95) and Max Pain ($2.14) forces dealer call-delta covering toward $11.73.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $XLAB• $4.8M Crowd Pool • Kalshi / Polymarket Composite
Contract: “XLAB Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
YES 28%NO 72%Trade / Inspect Odds →
SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

XLAB Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales →
▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (XLAB)

No recent open-market Form 4 cluster sales or emergency dumps flagged on XLAB. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring XLAB)

  • ✓Walkthrough of XLAB's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
XLAB // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -80.08%▼ DESCENDING CHANNEL
2026-11-03O $3.15H $3.15L $2.04C $2.04VOL 383.2K
RES: $4.32SUP: $0.00SMA50: $2.95SMA200: $7.96
$11.90$8.88$5.87$2.86$-0.16RES $4.32SUP $0.00$2.042026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

XLAB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 XLAB Butterfly Map → + Track XLAB →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on XLAB today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for XLAB. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for XLAB today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (XLAB)

Technology Rank #624 of 715 ⚔️ ZENA vs XLAB Full Matrix →

1. Head-to-Head Technology Peer Comparison (XLAB vs. ZENA, DUOT, AEYE, PDYN)

Industry: Computer Software: Prepackaged Software (222 Tracked Issuers)

Across 715 tracked Technology securities in the Roarable RQD universe, Exascale Labs Holdings Inc. (Class A) (XLAB) ranks #624 by composite RQD confidence (28/100, grade E) and #481 by equity capitalization ($182.7M). Within this direct 5-issuer industry benchmark cohort, PDYN leads on earnings valuation at 18.1x trailing P/E, while AEYE leads on capital efficiency and profitability with -12.1% ROIC and 78.3% gross margin. ZENA currently holds the highest overall quantitative score in the immediate peer group at 46/100 (D) compared with XLAB at 28/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
XLAB ACTIVE
Exascale Labs Holdings Inc. (Class A)
E 28/100 — 15.8% -23.7% -28.17% $182.7M Benchmark Subject
ZENA
ZenaTech Inc.
D 46/100 — — — -16.22% $175.5M /zena-vs-xlab →
DUOT
Duos Technologies Group Inc.
E 32/100 — 29.2% -15.9% -3.55% $195.1M /duot-vs-xlab →
AEYE
AudioEye Inc.
D- 41/100 — 78.3% -12.1% +2.46% $165.3M /aeye-vs-xlab →
PDYN
Palladyne AI Corp.
E 15/100 18.1x — -35.0% +0.75% $163.6M /pdyn-vs-xlab →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2025–FY2025)

SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0002109869 ↗

In its most recent audited fiscal period (FY2025, filed 2025-06-30), Exascale Labs Holdings Inc. (Class A) (XLAB) reported GAAP revenue of $7.0M , GAAP net income of -$7.7M, operating cash flow of -$1.0M, and free cash flow of -$1.0M . On the balance sheet, XLAB closed FY2025 with $0 in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-06-30 $7.0M -$7.7M -$1.0M -$1.0M — —

3. XLAB Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is XLAB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Exascale Labs Holdings Inc. (Class A) (NASDAQ: XLAB) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 28/100 at a spot price of $2.04 (-28.17% 1D, market cap $182.7M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 5/20, and Executive Insider Alignment 3/20. Across 715 tracked Technology issuers, XLAB ranks #624 in composite RQD confidence.

How does XLAB compare to ZENA and DUOT in the Technology sector?

Within the Technology sector (Computer Software: Prepackaged Software), XLAB carries a Roarable E (28/100 RQD), trailing P/E of N/A, gross margin of 15.8%, and ROIC of -23.7%. By comparison, ZENA (ZenaTech Inc.) holds a D grade (46/100 RQD, P/E N/A, ROIC —, cap $175.5M) and DUOT (Duos Technologies Group Inc.) posts a E grade (32/100 RQD, P/E N/A, ROIC -15.9%, cap $195.1M). Among the 5-stock peer group, PDYN leads on earnings multiple (18.1x) while AEYE leads on capital efficiency (-12.1% ROIC).

What are the biggest fundamental strengths and SEC risk factors for XLAB?

Per XLAB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0002109869), Exascale Labs Holdings Inc. (Class A) generated $7.0M in revenue, -$7.7M in net income, and -$1.0M in free cash flow against $0 in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is XLAB trading relative to its 50-day, 200-day, and 52-week technical levels?

XLAB last traded at $2.04 (-28.17% on volume of 685,121 shares), positioning the stock -30.85% below its 50-day simple moving average ($2.95) and -74.37% below its 200-day simple moving average ($7.96). Across its 52-week range of $0.78 to $11.17, XLAB sits at the 12.1% percentile with a 14-day RSI of 50.7 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.78 to $2.30).

Direct Sub-Reports: XLAB RQD Cockpit XLAB 12M Forecast XLAB Earnings & Move XLAB Dividends & DRIP XLAB Insiders & 13F XLAB Whale Options XLAB Profit Sankey XLAB News & Why
ROARABLE RATING BRIEF • RQD 28/100 (E) ✓ SEC XBRL & RQD VERIFIED

XLAB — Exascale Labs Holdings Inc. (Class A): What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-06-30

1. Roarable Rating Brief: What This Means to a Prospective Investor

Exascale Labs Holdings Inc. (Class A) (XLAB) earns a live Roarable RQD composite score of 28/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $2.04 (-28.17% 1D, market capitalization $182.7M).

  • Fundamental Cash Engine (7/20): Anchored by return on invested capital (ROIC) of -23.7%, gross margin of 15.8%, operating margin of -43.4%, and free cash flow yield of -0.50%.
  • Whale 13F & Options Flow (5/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (5/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 1/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Exascale Labs Holdings Inc. (Class A) is a NASDAQ-listed issuer in the Technology sector, Computer Software: Prepackaged Software industry (per the company profile). The company reported FY 2025 revenue of $7.0M (), and gross margin of 15.8% (per the market data).

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-06-30), Exascale Labs Holdings Inc. (Class A) (XLAB) reported $7.0M in annual revenue and -$7.7M in GAAP net income. Operating cash flow reached -$1.0M and free cash flow totaled -$1.0M, backed by $0 in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (E • RQD 28/100): Established market leader in Technology with deep daily trading liquidity. Free cash flow yield of -0.50% and institutional whale pillar of 5/20. With Fundamental Cash Engine at 7/20 and Institutional Whale Flow at 5/20, sustained execution supports upside toward the upper end of the $0.78 – $11.17 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -43.4% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream and downstream dependencies, sector correlations, and bottlenecks cannot be identified from the source data.

  • Key Question #1: Can XLAB sustain or expand its -43.4% operating margin and -23.7% ROIC against Computer Software: Prepackaged Software peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $7.0M and free cash flow of -$1.0M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is XLAB's equity valuation to Technology capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

XLAB Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Exascale Labs Holdings Inc. (Class A) (XLAB) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to XLAB Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

XLAB Bull vs. Bear Conversation Board — What's Your Call at $2.04?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON XLAB 🐻 33% BEARISH CONVICTION
1. Pick Your Side on XLAB:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
TA TapeReader_Pro RQD DEBATE OPENER • Price Action & Volume Trader 🐂 BULLISH 🎯 Target: $3.75 (+32.0%)
📌 Pinned Debate

The stock's extreme 52-week range from $0.78 to $11.17 and recent GREEN-flagged growth-plan coverage signal a volatile name with potent

Long XLAB at $2.84 targeting $3.75. The stock's extreme 52-week range from $0.78 to $11.17 and recent GREEN-flagged growth-plan coverage signal a volatile name with potential for sharp moves.. Institutional whale score is 5/20 and the risk/reward vs. the $0.78 52-week low is skewed heavily in favor of bulls.

RetailWhale_TX 🐂 BULL

@MeanReversion_88 Shorting a 5/20 institutional whale-flow stock at $2.84 is dangerous when funds are rotating into Technology.

ME MeanReversion_88 RQD DEBATE OPENER • Quantitative Statistical Arb 🐻 BEARISH 🎯 Target: $2.39 (-15.8%)
Spot @ $2.84

A 31/100 RQD score with negative ROIC of -23.7%, negative FCF yield of -0.5%, and a Piotroski F-Score of 1/9 points to weak fundamental

Here is the bear case nobody on the bull side wants to address on XLAB: A 31/100 RQD score with negative ROIC of -23.7%, negative FCF yield of -0.5%, and a Piotroski F-Score of 1/9 points to weak fundamentals and forensic risk.. At current EV/EBITDA multiples, even a small guidance miss in Computer Software: Prepackaged Software triggers a 12-15% air pocket.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%